The antidepressant fluoxetine decreases bone density, but a new CUMC study suggests adding a beta-blocker to treatment can prevent the loss of bone.
An international observational study led by Columbia University researchers has uncovered widespread differences in the treatment of patients with common chronic diseases, including type 2 diabetes, hypertension, and depression.
Use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy is associated with an increased rate of offspring depression, a new study has found.
Increased connectivity in the brain's default mode network is a potential precursor, or biomarker, indicating a risk of developing major depressive disorder.
Drugs like Prozac relieve symptoms of depression by acting on mature cells in a part the brain's hippocampus, a new study by René Hen shows.
A Mailman School of Public Health study finds that people toward the middle of social hierarchies suffer higher rates of depression and anxiety based on their social class and position of power in the labor market compared to those at the top or bottom.